5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE

• M.J. van Dijk,
• M.A.E. Rab,
• B.A. van Oirschot,
• J.F. Bos,
• C. Derichs,
• A.W. Rijneveld,
• M.H. Cnossen,
• E. Nur,
• B.J. Biemond,
• M. Bartels,
• J.J.M. Jans,
• W.W. van Solinge,
• R.E.G. Schutgens,
• R. van Wijk,
• E.J. van Beers

Affiliations

M.J. van Dijk

M.A.E. Rab

B.A. van Oirschot

J.F. Bos

C. Derichs

A.W. Rijneveld

M.H. Cnossen

E. Nur

B.J. Biemond

M. Bartels

J.J.M. Jans

W.W. van Solinge

R.E.G. Schutgens

R. van Wijk

E.J. van Beers